Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
about
Human CD46 enhances nitric oxide production in mouse macrophages in response to measles virus infection in the presence of gamma interferon: dependence on the CD46 cytoplasmic domainsExclusion of West Nile Virus Superinfection through RNA ReplicationMeasles virus spread and pathogenesis in genetically modified mice.Morbillivirus downregulation of CD46.Clinical isolates of measles virus use CD46 as a cellular receptor.Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism.Measles virus-induced suppression of immune responses.Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.The cellular receptor for measles virus--elusive no more.Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificitySLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent proteinExtent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus).Use of SLAM and PVRL4 and identification of pro-HB-EGF as cell entry receptors for wild type phocine distemper virus.Differential downregulation of CD46 by measles virus strains.Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strainsHuman cell receptor CD46 is down regulated through recognition of a membrane-proximal region of the cytoplasmic domain in persistent measles virus infectionCD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus.Identification of a cytoplasmic Tyr-X-X-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infectionArtificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding.Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.Down-regulation of CD46 by piliated Neisseria gonorrhoeae.Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro.Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppressionA role for CD81 and hepatitis C virus in hepatoma mobility.HIV-1, ubiquitin and ubiquitin-like proteins: the dialectic interactions of a virus with a sophisticated network of post-translational modifications.Envelope protein-mediated down-regulation of hepatitis B virus receptor in infected hepatocytes.A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cellsMeasles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus productionProteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro.Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion.Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake.V domain of human SLAM (CDw150) is essential for its function as a measles virus receptorMeasles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor.Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses.Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cellsCD46 expression does not overcome the intracellular block of measles virus replication in transgenic rats.Neutralization of measles virus infectivity and antibody-dependent cell-mediated cytotoxicity activity against an Epstein-Barr virus-infected cell line by intravenous immunoglobulin G [corrected].Mechanism of CD150 (SLAM) down regulation from the host cell surface by measles virus hemagglutinin protein.Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently.
P2860
Q27469706-1E23056D-8FB4-42BB-BF76-EBF24558046AQ27490309-9D97C2B1-B5D5-40AB-B972-430520CA1FA5Q33783885-B1F26A7D-2520-40C2-9178-FDAD27388CEAQ33786395-3F1BB4F2-238C-4EF8-B82E-FFD25D04F3E8Q33803102-C8EBEAFE-BA63-4E49-811E-10600C5F03FDQ33803482-1E6F8594-8167-4E10-B70E-3A18573216D6Q33817891-605CE96C-D3E7-4954-A107-6FE410C84675Q34015320-E201C945-8D63-4840-A680-70EAC89BD891Q34115190-6B269FB7-B66C-42BE-A57D-1757425B4825Q34263646-1EEE63BB-043B-408A-BA59-50E3F6CE5DD7Q34338440-386B283E-AA57-467A-A946-EDAC373BC2A3Q34340783-41562F41-CF5A-4454-8BAA-8FCC1B1FABF0Q34461467-F9978326-A43B-4FFD-8BA9-FE715E033DD6Q35235107-85BC6FAF-7F51-4F89-8A6C-29F57E31B4E7Q35851298-2570A55F-1A24-45DE-88E8-96DE9C854E05Q35863109-88AF7111-DC67-4A29-AE98-0523DB0303C7Q35870503-9853730C-D271-4050-BBF3-C0F23C629003Q35874613-044B8648-9A04-492A-9E60-AF9EF805A1AAQ35875948-D7D3517C-DE5D-46B8-A2E8-AA6599FE6B66Q35890362-4F383B14-25B0-4C6F-AA75-342DF9786799Q35973681-9E33821C-5F4D-4537-A402-302C23EE3426Q36371870-B6F0000B-945C-4D79-AE51-C7160D9E2D32Q36689706-E227E17E-6B30-4058-AC5B-95D03C364BDDQ36772633-C4B1BD99-2ECD-42B9-ACC3-FD3DDD149F7FQ37673172-668BC269-52BD-4DB8-93F4-BD80FDC959E0Q37970436-225A39FD-8FC2-46D1-8A83-E0360924E156Q39554543-16E85525-F8A0-4A91-B688-63FDEDD9E797Q39579051-F57E39A2-4BFA-41C4-AE70-2F310F68BD41Q39589324-CB8898B2-8C34-4ED5-8747-94DEC33DF309Q39589361-18502DFF-39F7-476A-9BBC-1703AC484731Q39592728-11354C6A-EC86-41A3-92C7-90CF5B1BB3A1Q39594404-337E6B7B-B2FD-42BA-A03A-337327FF36B3Q39602065-80F08C43-8959-4011-B712-5F670F40B229Q39602523-20080F02-BC25-4E5D-908E-8E7C6A012826Q39684160-A81D4AC6-D1EF-4BA0-9322-B2E6B50891FAQ39873046-D2A429D4-EBF4-4318-A125-27695937E5A4Q39881615-41145E78-C189-4B92-BA8F-FDCB475694A7Q39887603-AC6C7873-A4A5-4397-B41B-6107B497656EQ39960571-00731ED7-DF3B-436D-BCC5-E42D15C3808DQ40191590-E5A48D0B-B1F7-46C4-993F-B8D230C1DC25
P2860
Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Receptor usage and differentia ...... wild-type and vaccine strains.
@ast
Receptor usage and differentia ...... wild-type and vaccine strains.
@en
Receptor usage and differentia ...... wild-type and vaccine strains.
@nl
type
label
Receptor usage and differentia ...... wild-type and vaccine strains.
@ast
Receptor usage and differentia ...... wild-type and vaccine strains.
@en
Receptor usage and differentia ...... wild-type and vaccine strains.
@nl
prefLabel
Receptor usage and differentia ...... wild-type and vaccine strains.
@ast
Receptor usage and differentia ...... wild-type and vaccine strains.
@en
Receptor usage and differentia ...... wild-type and vaccine strains.
@nl
P2093
P2860
P50
P356
P1476
Receptor usage and differentia ...... wild-type and vaccine strains.
@en
P2093
Brinckmann U
Dunster LM
Liebert UG
Schneider-Schaulies S
Schnorr JJ
P2860
P304
P356
10.1073/PNAS.92.9.3943
P407
P577
1995-04-01T00:00:00Z